Announcement
BUHLMANN Diagnostics Corp is pleased to announce the collaboration with QuidelOrtho, making the BÜHLMANN fCAL® turbo & fPELA® turbo assays now available for use on QuidelOrtho’s VITROS™ Systems.
Benefits of this Collaboration
Directly applying the fCAL® turbo and fPELA® turbo on QuidelOrtho analyzers streamlines testing procedures for modern core labs, providing rapid and reliable results with minimal hands-on time.
Launch
When is the anticipated product launch happening in the US?
Availability on the VITROS™ platform will begin globally in July 2025.
Quick Connect
Assays
- fCAL® turbo (calprotectin) assay and fPELA® turbo (pancreatic elastase) assay are now available:
- US & Outside the US:
- VITROS™ XT 7600 and 5600 Integrated Systems
- VITROS™ 4600 Chemistry System
- US & Outside the US:
CALEX® Cap Stool Preparation Device
CALEX® Cap Stool Preparation Device: When used in combination with both assays, the BÜHLMANN CALEX® Cap enables seamless integration into Total Laboratory Automation (TLA) by allowing direct application onto analyzers, minimizing the complexity of sample processing. The device is designed to optimize stool extraction efficiency, helping to maximize sample stability and yield, and ultimately delivering robust, reliable, and accurate results for both fecal calprotectin and pancreatic elastase testing (one sample for two assays).
